Filing Details
- Accession Number:
- 0001181431-14-029377
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-08-15 18:05:35
- Reporting Period:
- 2014-06-16
- Filing Date:
- 2014-08-15
- Accepted Time:
- 2014-08-15 18:05:35
- Original Submission Date:
- 2014-06-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070336 | Achillion Pharmaceuticals Inc | ACHN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1215914 | E Gary Frashier | C/O Achillion Pharmaceuticals, Inc. 300 George Street New Haven CT 06511 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-16 | 3,750 | $1.05 | 8,750 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-16 | 3,750 | $8.00 | 5,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-06-16 | 16,250 | $3.28 | 21,250 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-16 | 16,250 | $8.00 | 5,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-06-16 | 35,000 | $3.10 | 40,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-16 | 35,000 | $8.00 | 5,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- This amendment is being filed solely to correct Table I, column 5 of the Form 4 filed on June 17, 2014 (the "Original Form 4"). The amounts shown in Table I, column 5 of the Original Form 4 inadvertently omitted 5,000 shares of common stock beneficially owned by the reporting person. The amounts shown in Table I, column 5 of this amendment represent the correct number of shares of common stock beneficially owned by the reporting person following the transactions previously reported in Table I, column 5 of the Original Form 4. Except for the foregoing, no new or revised transactions or holdings are being reported by this amendment, and all other information reported in the Original Form 4 remains the same.
Billionaire Hedge Funds
